---
figid: PMC8066213__diagnostics-11-00640-g001
figlink: pmc/articles/PMC8066213/figure/diagnostics-11-00640-f001/
number: F1
caption: Inhibition of vascular endothelial growth factor (VEGF)/vascular endothelial
  growth factor receptor (VEGFR) signaling. Numerous strategies exist to inhibit VEGF/VEGFR
  signaling. VEGF can be blocked by monoclonal antibodies (mAbs) (bevacizumab) or
  by fusion proteins (aflibercept). Its receptor, VEGFR, can be targeted by fully
  humanized monoclonal antibodies (ramucirumab). The receptor can also be targeted
  for its intracellular tyrosine kinase activity (tyrosine kinase inhibitors, TKIs).
  Finally, one strategy consists of inhibiting the downstream signaling pathways of
  VEGFR by targeting either the Raf (Rapidly Accelerated Fibrosarcoma)/mitogen-activated
  protein kinase (MAPK)/ERK (Extracellular signal-Regulated Kinase) pathway with B-Raf
  inhibitors (dabrafenib, vemurafenib), or the endothelial nitric oxide synthase (eNOS)
  pathway (dasatinib, ponatinib) or the mammalian target of rapamycin (mTOR) pathway
  (everolimus, temsirolimus, ridaforolimus).
pmcid: PMC8066213
papertitle: Nephrotoxicity of Anti-Angiogenic Therapies.
reftext: Margaux Van Wynsberghe, et al. Diagnostics (Basel). 2021 Apr;11(4):640.
pmc_ranked_result_index: '38095'
pathway_score: 0.9415235
filename: diagnostics-11-00640-g001.jpg
figtitle: Inhibition of vascular endothelial growth factor (VEGF)/vascular endothelial
  growth factor receptor (VEGFR) signaling
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8066213__diagnostics-11-00640-g001.html
  '@type': Dataset
  description: Inhibition of vascular endothelial growth factor (VEGF)/vascular endothelial
    growth factor receptor (VEGFR) signaling. Numerous strategies exist to inhibit
    VEGF/VEGFR signaling. VEGF can be blocked by monoclonal antibodies (mAbs) (bevacizumab)
    or by fusion proteins (aflibercept). Its receptor, VEGFR, can be targeted by fully
    humanized monoclonal antibodies (ramucirumab). The receptor can also be targeted
    for its intracellular tyrosine kinase activity (tyrosine kinase inhibitors, TKIs).
    Finally, one strategy consists of inhibiting the downstream signaling pathways
    of VEGFR by targeting either the Raf (Rapidly Accelerated Fibrosarcoma)/mitogen-activated
    protein kinase (MAPK)/ERK (Extracellular signal-Regulated Kinase) pathway with
    B-Raf inhibitors (dabrafenib, vemurafenib), or the endothelial nitric oxide synthase
    (eNOS) pathway (dasatinib, ponatinib) or the mammalian target of rapamycin (mTOR)
    pathway (everolimus, temsirolimus, ridaforolimus).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - FLT1
  - FLT4
  - KDR
  - MAPK3
  - MAPK1
  - ARAF
  - BRAF
  - RAF1
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MTOR
  - Tyrosine
  - Axitinib
  - Sunitinib
  - Sorafenib
  - Vemurafenib
  - Dabrafenib
  - Dasatinib
  - Ponatinib
  - Everolimus
  - Temsirolimus
  - Ridaforolimus
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Raf/MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf/MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf/MAPK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf/MAPK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf/MAPK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Raf/MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: B-raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals:
- word: Tyrosine
  source: ''
  identifier: ''
- word: Axitinib
  source: MESH
  identifier: C503983
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Dasatinib
  source: MESH
  identifier: C488369
- word: Ponatinib
  source: MESH
  identifier: C545373
- word: Everolimus
  source: MESH
  identifier: C107135
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Ridaforolimus
  source: MESH
  identifier: C515074
diseases: []
figid_alias: PMC8066213__F1
redirect_from: /figures/PMC8066213__F1
figtype: Figure
---
